$45M additional funding bolsters development of canine longevity drugMarch 25, 2024The latest financing round brings the total funds raised for the first FDA-approved dog lifespan extension drug to $125M
Education Center - SponsoredA "new frontier" for in-clinic veterinary cancer screeningby • ZoetisCancer screening can be a stressful time for clients. However, deep learning artificial intelligence (AI) is changing the game for cytology. AI Masses – a new addition to Zoetis’s Vetscan Imagyst® platform – offers veterinarians analysis of potentially cancerous cells at the point of care, for more timely and individualized diagnosis and treatment.
Canine longevity drug starts clinical trialFebruary 1, 2024A whippet named Boo is the first dog dosed in the study to demonstrate healthy lifespan extension in dogs treated with LOY-002
